Zinc Glycinate

Take 1-2 tablets daily, as a dietary supplement, as directed by your physician. HOW SUPPLIED Nicomide ® Tablets are white-colored, oval-shaped tablets debossed on one side with “342”, and are supplied in bottles of 60 tablets (75854-343-60). The listed product number is not a National Drug Code. Instead, Avion has assigned a product code formatted according to standard industry practice in order to comply with the formatting requirements of pharmacy and healthcare insurance computer systems. STORAGE Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.] MANUFACTURED FOR: Avion Pharmaceuticals, LLC Alpharetta, GA 30022 1-888-61-AVION Rev. 1117-01 *Subject to one or more claims of U.S. Patent Nos. 7,582,418, 7,838,042 and 8,425,956. Nicomide ® is a registered trademark of Acella Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.

If you are pregnant, nursing, or taking medication, consult your doctor before use. Use only under the advice and supervision of a physician if you have a history of jaundice, liver disease or diabetes. Abnormal liver function tests have been reported in persons taking daily doses of 500 mg or more of niacinamide. Folate intake should not exceed 250% of the Daily Value (1,000 mcg). PREGNANCY & NURSING MOTHERS Nicomide ® Tablets is not indicated for use as a prenatal/postnatal multivitamin for lactating and nonlactating mothers. Physicians and medical practitioners should administer Nicomide® Tablets with caution to patients who are pregnant, lactating and/or taking medication. ADVERSE REACTIONS Allergic sensitization has been reported rarely following oral and parental administration of Folate.

1. 1Headache411%
2. 2Exposure During Pregnancy38.3%
3. 3Rosacea38.3%
4. 4Abdominal Pain Upper25.6%
5. 5Abortion Spontaneous25.6%
6. 6Acne25.6%
7. 7Amenorrhoea25.6%
8. 8Application Site Burning25.6%
9. 9Application Site Irritation25.6%
10. 10Application Site Papules25.6%
11. 11Application Site Paraesthesia25.6%
12. 12Condition Aggravated25.6%
13. 13Eye Pain25.6%
14. 14Fatigue25.6%
15. 15Metrorrhagia25.6%

The 2 most recently updated of 2 ClinicalTrials.gov registrations naming Zinc Glycinate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne
  Completed · Interventional · 40 enrolled · Ablon Skin Institute Research Center
  NCT05879406updated 2025-04-06
• Zinc Sulphate vs. Zinc Amino Acid Chelate
  Completed · Phase 4 · Interventional · 360 enrolled · CES University
  NCT01791608updated 2013-02-15